7AK1
Human MALT1(329-729) in complex with a chromane urea containing inhibitor
Summary for 7AK1
Entry DOI | 10.2210/pdb7ak1/pdb |
Descriptor | Mucosa-associated lymphoid tissue lymphoma translocation protein 1, 1-(3-chloranyl-4-methoxy-phenyl)-3-[7-[(3~{S})-3-(methoxymethyl)morpholin-4-yl]-2-methyl-pyrazolo[1,5-a]pyrimidin-6-yl]urea, MAGNESIUM ION, ... (4 entities in total) |
Functional Keywords | inhibitor, complex, allosteric inhibitor, hydrolase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 46164.60 |
Authors | Renatus, M. (deposition date: 2020-09-29, release date: 2020-12-09, Last modification date: 2024-01-31) |
Primary citation | Pissot Soldermann, C.,Simic, O.,Renatus, M.,Erbel, P.,Melkko, S.,Wartmann, M.,Bigaud, M.,Weiss, A.,McSheehy, P.,Endres, R.,Santos, P.,Blank, J.,Schuffenhauer, A.,Bold, G.,Buschmann, N.,Zoller, T.,Altmann, E.,Manley, P.W.,Dix, I.,Buchdunger, E.,Scesa, J.,Quancard, J.,Schlapbach, A.,Bornancin, F.,Radimerski, T.,Regnier, C.H. Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing. J.Med.Chem., 63:14576-14593, 2020 Cited by PubMed: 33252239DOI: 10.1021/acs.jmedchem.0c01245 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.507 Å) |
Structure validation
Download full validation report